Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lissandra Dal Lago

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of Geriatric Oncology|January 29, 2017
Old age: An extra risk for febrile neutropenia?Jean Klastersky, Lissandra Dal Lago
The Oncologist|August 13, 2008
Selected combination therapy with sorafenib: a review of clinical data and perspectives in advanced solid tumorsLissandra Dal Lago, Véronique D'Hondt, Ahmad Awada
Current Opinion in Oncology|June 17, 2020
Use of granulocyte-colony stimulating factors in older patients: a review of recently published dataJean A Klastersky, Lissandra Dal Lago, Yassine Lalami
Expert Review of Anticancer Therapy|September 2, 2016
What is the role of informed decision-making?Noam Pondé, Lissandra Dal Lago, Hatem A Azim
European Journal of Cancer (Oxford, England : 1990)|January 8, 2008
Current perspectives of epothilones in breast cancerFatima Cardoso, Evandro de Azambuja, Lissandra Dal Lago
Expert Review of Anticancer Therapy|March 25, 2016
Adjuvant chemotherapy in elderly patients with breast cancer: key challengesNoam Pondé, Lissandra Dal Lago, Hatem A Azim
European Journal of Case Reports in Internal Medicine|February 15, 2021
Rare Features of Dermatomyositis in a Patient with Ovarian CancerLissandra Dal Lago, Frédéric Vandergheynst, Ahmad Awada, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2006
Multinational clinical trials in oncology and post-trial benefits for host countries: where do we stand?Max S Mano, Daniela D Rosa, Lissandra Dal Lago
Cancer Treatment Reviews|September 11, 2007
Molecular-targeted therapies: lessons from years of clinical developmentDaniela D Rosa, Gustavo Ismael, Lissandra Dal Lago, et al.
Investigational New Drugs|March 15, 2012
Clinical development of insulin-like growth factor receptor--1 (IGF-1R) inhibitors: at the crossroad?Andrea Gombos, Otto Metzger-Filho, Lissandra Dal Lago, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of Geriatric Oncology|January 29, 2017
Old age: An extra risk for febrile neutropenia?Jean Klastersky, Lissandra Dal Lago
The Oncologist|August 13, 2008
Selected combination therapy with sorafenib: a review of clinical data and perspectives in advanced solid tumorsLissandra Dal Lago, Véronique D'Hondt, Ahmad Awada
Current Opinion in Oncology|June 17, 2020
Use of granulocyte-colony stimulating factors in older patients: a review of recently published dataJean A Klastersky, Lissandra Dal Lago, Yassine Lalami
Expert Review of Anticancer Therapy|September 2, 2016
What is the role of informed decision-making?Noam Pondé, Lissandra Dal Lago, Hatem A Azim
European Journal of Cancer (Oxford, England : 1990)|January 8, 2008
Current perspectives of epothilones in breast cancerFatima Cardoso, Evandro de Azambuja, Lissandra Dal Lago
Expert Review of Anticancer Therapy|March 25, 2016
Adjuvant chemotherapy in elderly patients with breast cancer: key challengesNoam Pondé, Lissandra Dal Lago, Hatem A Azim
European Journal of Case Reports in Internal Medicine|February 15, 2021
Rare Features of Dermatomyositis in a Patient with Ovarian CancerLissandra Dal Lago, Frédéric Vandergheynst, Ahmad Awada, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2006
Multinational clinical trials in oncology and post-trial benefits for host countries: where do we stand?Max S Mano, Daniela D Rosa, Lissandra Dal Lago
Cancer Treatment Reviews|September 11, 2007
Molecular-targeted therapies: lessons from years of clinical developmentDaniela D Rosa, Gustavo Ismael, Lissandra Dal Lago, et al.
Investigational New Drugs|March 15, 2012
Clinical development of insulin-like growth factor receptor--1 (IGF-1R) inhibitors: at the crossroad?Andrea Gombos, Otto Metzger-Filho, Lissandra Dal Lago, et al.
Pageof 5